KRAS and BRAF Mutations in 203 Esophageal Squamous Cell Carcinomas: Pyrosequencing Technology and Literature Review
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
KRAS and BRAF Mutations in 203 Esophageal Squamous Cell Carcinomas: Pyrosequencing Technology and Literature Review
Authors
Keywords
Epidermal Growth Factor Receptor, Esophageal Squamous Cell Carcinoma, KRAS Mutation, BRAF Mutation, Whole Genome Amplification
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 20, Issue S3, Pages 485-491
Publisher
Springer Nature
Online
2012-12-29
DOI
10.1245/s10434-012-2819-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic Value of BRAF V600 Mutations in Melanoma Patients After Resection of Metastatic Lymph Nodes
- (2012) Stéphanie Moreau et al. ANNALS OF SURGICAL ONCOLOGY
- BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer
- (2012) Rachel N. Grisham et al. CANCER
- Landscape of EGFR signaling network in human cancers: Biology and therapeutic response in relation to receptor subcellular locations
- (2012) Woody Han et al. CANCER LETTERS
- Specific Mutations in KRAS Codons 12 and 13, and Patient Prognosis in 1075 BRAF Wild-Type Colorectal Cancers
- (2012) Y. Imamura et al. CLINICAL CANCER RESEARCH
- Pyrosequencing data analysis software: a useful tool for EGFR, KRAS, and BRAF mutation analysis
- (2012) Shanxiang Shen et al. Diagnostic Pathology
- Antitumoral Efficacy of the Protease Inhibitor Gabexate Mesilate in Colon Cancer Cells Harbouring KRAS, BRAF and PIK3CA Mutations
- (2012) Giovanni Brandi et al. PLoS One
- High-Throughput Genotyping in Metastatic Esophageal Squamous Cell Carcinoma Identifies Phosphoinositide-3-Kinase and BRAF Mutations
- (2012) Chi Hoon Maeng et al. PLoS One
- Current Developments in the Management of Locally Advanced Esophageal Cancer
- (2012) Michael J. McNamara et al. Current Oncology Reports
- Comprehensive Registry of Esophageal Cancer in Japan, 2004
- (2012) Soji Ozawa et al. Esophagus
- Identification of the MEK1(F129L) Activating Mutation as a Potential Mechanism of Acquired Resistance to MEK Inhibition in Human Cancers Carrying the B-RafV600E Mutation
- (2011) H. Wang et al. CANCER RESEARCH
- Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803
- (2011) S. Ogino et al. CLINICAL CANCER RESEARCH
- Identification of EGFR and KRAS mutations in Chinese patients with esophageal squamous cell carcinoma
- (2011) Q.-W. Liu et al. DISEASES OF THE ESOPHAGUS
- Long-term outcomes following neoadjuvant chemoradiotherapy in patients with clinical T2N0 esophageal squamous cell carcinoma
- (2011) W.-H. Chen et al. DISEASES OF THE ESOPHAGUS
- A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction
- (2011) David J. Adelstein et al. INVESTIGATIONAL NEW DRUGS
- Esophageal Cancer: A Critical Evaluation of Systemic Second-Line Therapy
- (2011) Christiane Maria Rosina Thallinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted therapies: how personal should we go?
- (2011) Miriam Martini et al. Nature Reviews Clinical Oncology
- 7th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction
- (2010) Thomas W. Rice et al. ANNALS OF SURGICAL ONCOLOGY
- A phase 2 trial of erlotinib in patients with previously treated squamous cell and adenocarcinoma of the esophagus
- (2010) David H. Ilson et al. CANCER
- Outcomes from chemoradiotherapy for patients with esophageal cancer
- (2010) A. Z. Pantling et al. DISEASES OF THE ESOPHAGUS
- KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie
- (2009) S. Lorenzen et al. ANNALS OF ONCOLOGY
- KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803
- (2009) S. Ogino et al. CLINICAL CANCER RESEARCH
- Are RAS mutations predictive markers of resistance to standard chemotherapy?
- (2009) Yohann Loriot et al. Nature Reviews Clinical Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search